| Preview | Issue Date | Title / Name | Author(s) | Type |
 | 2015 | A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial | Davidson, A.; Veillard, A. S.; Tognela, A.; Chan, M. M.; Hughes, B. G., et al | Journal Article | |
| 2020 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2+/HR+ metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard H.; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| Jan-2023 | Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer | Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally, et al | Journal Article | |
| 2022 | CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort | Javaid, Anadil; Lok, Sheau Wen; Wong, Vanessa; Baron-Hay, Sally; Boyle, Fran, et al | Conference Paper | |
 | Jun-2022 | Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer | Tie, Jeanna; Cohen, Joshua D.; Lahouel, Kamel; Lo, Serigne N.; Wang, Yuxuan, et al | Journal Article | |
 | 2024 | Circulating tumor DNA analysis informing adjuvant chemotherapy in locally advanced rectal cancer: The randomized AGITG DYNAMIC-Rectal study | Tie, Jeanne; Cohen, Joshua D.; Yuxuan, Wang; Gonzalez Ginestet, Pablo; Wong, Rachel, et al | Conference Paper | |
 | 30-Aug-2024 | Nivolumab and Ipilimumab combination treatment in advanced intrahepatic cholangiocarcinoma and gallbladder cancer | Klein, O.; Carlino, M. S.; Brown, M. P.; Harris, S.; Gunjur, A., et al | Conference Poster | |
 | Nov-2015 | A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australian lung cancer trials group Nitro trial | Hayes, Theresa M.; Hayes, Theresa M.; Davidson, Adee | Journal Article | |
| 2021 | Real world outcomes in elderly women with HER2 positive advanced breast cancer | Evans, Nicole; Anton, Angelyn; Wong, Rachel; Lok, Sheau Wen; De Boer, Richard, et al | Conference Paper | |
| May-2022 | RESILIENT part 1: a phase 2 dose-exploration and dose-expansion study of second-line liposomal irinotecan in adults with small cell lung cancer | Spigel, David R.; Paz-Ares, Luis; Moore, Yan; Zhang, Bin; Dowlati, Afshin, et al | Journal Article | |
 | 2007 | Severe palmar-plantar erythema in a patient with breast cancer receiving doxorubicin-cyclophosphamide Chemotherapy | Damasiewicz, M. J.; Chionh, F. J. M.; Hayes, Theresa M.; Hayes, Theresa M. | Journal Article | |
| 2015 | Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin bound (nab)-paclitaxel for newly diagnosed breast cancer (BC). | Khasraw, Mustafa; Mukaro, Violet; West, Linda; Brandt, Conrad; Woollett, Anne Maree, et al | Conference Paper | |
| 2019 | The prevalence and aetiology of distress experienced by women with primary breast cancer upon commencement of neoadjuvant chemotherapy compared to first-line surgical intervention and those commencing adjuvant chemotherapy | Hay, Rebecca; Pascoe, Elizabeth; Hay, Rebecca | Journal Article | |
